Diabetes

The FDA said it is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014.

Here is some of the latest news in diabetes from our sister publication Pharmacy Times®.

When drug developers were forced to conduct cardiovascular outcomes trials for SGLT2 inhibitors, they found a surprise: the drugs created for type 2 diabetes (T2D) had strong benefits for heart failure. And the same has proven true in sotagliflozin.

There is a role for pharmacists and pharmacy quality measures in addressing the public health challenge of diabetes, according to speakers at a recent virtual meeting this week.

The researchers undertook the study on diabetes in patients with stroke amid evidence of mortality and hospitalization for some cardiovascular complications declining.

Soft tissue and bone infections, urinary tract infections, stroke, and electrolyte disorder top the reasons why patients with diabetes are admitted to the hospital at greater frequency and cost compared with patients without the disease, according to a new study.

A roundup of diabetes news you may have missed from across MJH Life Sciences™.

Oral semaglutide, when used with basal insulin, is as effective or better than the injectable version in treating type 2 diabetes (T2) while providing similar tolerability.

Diabetes affects corneal endothelial cells in patients that are older, have suffered with the disease for at least a decade, and have high glycated hemoglobin (A1C).

Patients with diabetes who have small kidney size at the beginning of peritoneal dialysis (PD) have a substantial risk of mortality.

Black patients, female patients, and those of lower socioeconomic status are less likely to be prescribed sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes (T2D).

The authors said their work is an effort towards making more tailored therapy a reality.

Among patients with type 2 diabetes (T2D) and weight issues, cognitive advantages that women hold over men when both are affected are preserved into later life but are eroded for women carrying apolipoprotein E ε4 alleles.

A high proportion of Marshallese, or Marshall Islanders, living on the mainland Unites States, have undiagnosed hypertension and type 2 diabetes (T2D), according to findings that will be used to address disparities in Native Hawaiian and Pacific Islander populations.

A machine learning model using the gut microbiome may serve as a successful predictive measure for type 2 diabetes development.

Women who received a type 1 diabetes (T1D) diagnosis prior to menstruation onset exhibited shorter reproductive periods compared with healthy controls.

A review found that a low-carbohydrate diet may lead patients with type 2 diabetes to experience disease remission, potentially providing new insight into how clinicians can help patients better manage their disease, investigators concluded.

Investigators found 10 main themes characterizing the differences between primary care clinics classified as high- and low-performing in distributing diabetes care.

New research shows eating before 8:30 am may reduce risk factors for type 2 diabetes as individuals who did so exhibited lower blood sugar levels and less insulin resistance.

Between 1999 and 2018, Black adults living in rural regions of the United States experienced high mortality rates due to diabetes, high blood pressure, heart disease, and stroke compared with White adults, according to new research published in the Journal of the American College of Cardiology.

Medicare Advantage beneficiaries with type 2 diabetes (T2D) may be less likely than commercially insured individuals to be treated with newer medications to lower glucose levels, according to results of a retrospective cohort study published in JAMA Network Open.

The Diabetes Care Rewards program offers a business case for health plans to promote engagement through use of contingent incentives, thus improving health outcomes and lowering costs.

When comparing 1-step and 2-step approaches for diagnosing gestational diabetes among pregnant women, researchers found no significant between-group differences in the risks of primary outcomes relating to perinatal and maternal complications.

Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.

Timing of bout-related moderate-to-vigorous physical activity (MVPA) is associated with cardiorespiratory fitness and cardiovascular risk among men with type 2 diabetes (T2D), independent of bout-related MVPA volume and intensity, according to research published in Diabetes Care.

Medicare Advantage enrollees are more likely to be treated with metformin and sulfonylureas and less likely to receive costly newer medications than those in traditional Medicare.

Collaboration enabled ChristianaCare to significantly grow its population of patients with well-controlled disease, thanks to a diabetes control roadmap that ensured both physical and emotional health needs were met through interprofessional partnerships.

Genetically decreased vitamin D levels are unlikely to have a large effect on risk of type 1 diabetes, according to results of a Mendelian randomization study published in PLOS Medicine.

Low-quality maternal diets may increase the odds of offspring being considered overweight or obese, according to study results published in BMC Medicine.